Curious to see your top suppliers emissions?
Book a demo for a pilot project
HOOKIPA Pharma Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 11 months agohookipapharma.com
HOOKIPA Pharma Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. Founded in 2011, HOOKIPA has made significant strides in the field, particularly with its proprietary platform that harnesses the power of viral vectors to stimulate robust immune responses.
The company operates primarily in the oncology and infectious disease sectors, offering unique therapies that stand out for their ability to target specific antigens effectively. HOOKIPA's lead product candidates, including its promising therapies in clinical trials, exemplify its commitment to advancing treatment options. With a strong market position and notable achievements in research and development, HOOKIPA Pharma continues to be at the forefront of biopharmaceutical innovation, striving to improve patient outcomes globally.
18
DitchCarbon score
-22 vs industry average
HOOKIPA Pharma Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at HOOKIPA Pharma Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for HOOKIPA Pharma Inc. yet.
HOOKIPA Pharma Inc.'s reported carbon emissions
HOOKIPA Pharma Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, HOOKIPA Pharma's climate commitments and initiatives remain unspecified, and there is no inherited emissions data from a parent or related organization. The company appears to be in the early stages of establishing its climate strategy within the pharmaceutical industry context.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
HOOKIPA Pharma Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for HOOKIPA Pharma Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
HOOKIPA Pharma Inc.11 months ago
18
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more